Osteoarthritis: Local antagonism of endothelin-1 and bradykinin receptors improves OA pain and joint morphology in rats

Nature Reviews Rheumatology

Volumn 7, Issue 7, 2011, Pages 375-

  Warde, Nick ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR ANTAGONIST; COLLAGEN; COLLAGEN TYPE 2; COLLAGENASE 3; ENDOTHELIN 1 DERIVATIVE; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR A; INTERSTITIAL COLLAGENASE; PROTEOGLYCAN; UNCLASSIFIED DRUG;

ARTHRALGIA; BONE REMODELING; DISEASE COURSE; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME INHIBITION; JOINT; MORPHOLOGY; NOCICEPTION; NONHUMAN; NOTE; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

EID: 79960024197     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2011.82     Document Type: Note

References (1)

1. Kaufman, G. N. et al. Nociceptive tolerance is improved by bradykinin receptor B1 antagonism and joint morphology is protected by both endothelin type A and bradykinin receptor B1 antagonism in a surgical model of osteoarthritis. Arthritis Res. Ther. 13, R76 (2011)